[go: up one dir, main page]

TR200002786T2 - Meloksikam için yeni galenik bir formülasyon. - Google Patents

Meloksikam için yeni galenik bir formülasyon.

Info

Publication number
TR200002786T2
TR200002786T2 TR2000/02786T TR200002786T TR200002786T2 TR 200002786 T2 TR200002786 T2 TR 200002786T2 TR 2000/02786 T TR2000/02786 T TR 2000/02786T TR 200002786 T TR200002786 T TR 200002786T TR 200002786 T2 TR200002786 T2 TR 200002786T2
Authority
TR
Turkey
Prior art keywords
meloxicam
galenic formulation
new galenic
manufacture
new
Prior art date
Application number
TR2000/02786T
Other languages
English (en)
Inventor
Thomas Bock Dr.
Sagm�Ller Paul
Peter Sieger Dr.
Dietrich T�Rck Dr.
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of TR200002786T2 publication Critical patent/TR200002786T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bulusun konusu, agiz yoluyla uygulanan, içindeki etkin maddenin hizla serbest birakildigi ve emildigi bir ilaç biçiminin imalatina yönelik olarak anorganik ya da organik bir baz kaynakli meloksikam tuzunun, agri tedavisindeki kullanimi, dogrudan tablet olusturma yoluyla üretilebilen ilgili ilaç biçimleri ve bunlarin imalatina yönelik yöntemdir.
TR2000/02786T 1998-03-27 1999-03-23 Meloksikam için yeni galenik bir formülasyon. TR200002786T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105569A EP0945134A1 (de) 1998-03-27 1998-03-27 Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation

Publications (1)

Publication Number Publication Date
TR200002786T2 true TR200002786T2 (tr) 2001-01-22

Family

ID=8231652

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02786T TR200002786T2 (tr) 1998-03-27 1999-03-23 Meloksikam için yeni galenik bir formülasyon.

Country Status (24)

Country Link
US (1) US6869948B1 (tr)
EP (2) EP0945134A1 (tr)
JP (1) JP3639532B2 (tr)
KR (1) KR100589299B1 (tr)
CN (1) CN1163231C (tr)
AR (1) AR016197A1 (tr)
AT (1) ATE254920T1 (tr)
AU (1) AU762322C (tr)
BR (1) BR9909192A (tr)
CA (1) CA2326517C (tr)
DE (1) DE59907871D1 (tr)
DK (1) DK1083902T3 (tr)
ES (1) ES2212547T3 (tr)
HU (1) HUP0101246A3 (tr)
IL (2) IL137652A0 (tr)
NO (1) NO326852B1 (tr)
NZ (1) NZ507382A (tr)
PL (1) PL192967B1 (tr)
PT (1) PT1083902E (tr)
TR (1) TR200002786T2 (tr)
TW (1) TWI236914B (tr)
UY (1) UY25441A1 (tr)
WO (1) WO1999049867A1 (tr)
ZA (1) ZA200004178B (tr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1158075C (zh) * 1998-12-01 2004-07-21 诺沃挪第克公司 新药物组合物及其制备方法
WO2001037838A1 (en) * 1999-11-24 2001-05-31 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
EP1303273A1 (en) 2000-05-26 2003-04-23 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US7120656B1 (en) 2000-10-04 2006-10-10 Marvell International Ltd. Movable tap finite impulse response filter
CZ20032568A3 (cs) * 2001-02-27 2004-04-14 Ranbaxy Laboratories Limited Rychle rozpustné tablety enzymového inhibitoru cyklooxygenázy-2
EP1250921A1 (en) * 2001-04-21 2002-10-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Fast disintegrating meloxicam tablet
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1348436A1 (en) * 2002-03-30 2003-10-01 Boehringer Ingelheim International GmbH Meloxicam suppositories
GB0209257D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
DK1562567T3 (en) 2002-11-22 2017-07-17 Gruenenthal Gmbh Combination of selected analgesics with COX II inhibitors
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
NZ542852A (en) * 2003-03-17 2008-09-26 Japan Tobacco Inc Pharmaceutical compositions of CETP inhibitors
KR100620239B1 (ko) * 2004-01-05 2006-09-13 신일제약주식회사 용해도 및 안정성이 향상된 경구투여용 멜록시캄 고형제조성물
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
US20060025408A1 (en) * 2004-08-02 2006-02-02 Sundaram Venkataraman Process for the preparation of crystalline form-1 of 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
EP3056492B1 (en) 2004-10-08 2021-09-22 AbbVie Inc. Meglumine salt and crystalline forms thereof of a drug (delafloxacin)
HU227359B1 (en) * 2004-12-18 2011-04-28 Egis Gyogyszergyar Nyilvanosan Mikodi Ruszvunytarsasag Process for producing meloxicam and meloxicam potassium salt of high purity
DE602005009016D1 (de) 2004-12-06 2008-09-25 Janssen Pharmaceutica Nv Orale suspension mit meloxicam
EP1848270B1 (en) 2005-02-17 2014-05-21 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
CN101222911A (zh) * 2005-07-15 2008-07-16 特瓦制药工业有限公司 新的制粒方法及由此制备的颗粒
EP1942902A1 (en) * 2005-09-30 2008-07-16 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
US7572641B2 (en) 2005-11-22 2009-08-11 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions comprising meloxicam and methods of their preparation
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
US20070281927A1 (en) * 2006-06-06 2007-12-06 Shanthakumar Tyavanagimatt Anti-inflammatory and analgesic compositions and related methods
EP2244712B1 (en) * 2008-01-22 2015-08-05 Thar Pharmaceuticals Inc. In vivo studies of crystalline forms of meloxicam
TR200809200A1 (tr) 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
MX389960B (es) 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US8791105B2 (en) 2010-07-14 2014-07-29 Kansas State University Research Foundation Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration
US20170281640A1 (en) * 2016-04-04 2017-10-05 Productos Maver, S.A. De C.V. Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
EP3877385A1 (en) * 2018-11-05 2021-09-15 Mylan Laboratories Ltd. Meloxicam co-crystals
EP3958841A1 (en) 2019-04-22 2022-03-02 Mylan Specialty L.P. Meloxicam co-crystal compositions
US20240277726A1 (en) 2020-11-06 2024-08-22 Mylan Laboratories Ltd Pharmaceutical composition comprising meloxicam
CN112587497A (zh) * 2020-12-25 2021-04-02 苏州中化药品工业有限公司 一种美洛昔康混悬液胶囊剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
CA2237306C (en) * 1995-11-13 2008-10-07 Pitmy International N.V. Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
US6284269B1 (en) * 1997-08-27 2001-09-04 Hexal Ag Pharmaceutical compositions of meloxicam with improved solubility and bioavailability

Also Published As

Publication number Publication date
NZ507382A (en) 2003-08-29
US6869948B1 (en) 2005-03-22
NO326852B1 (no) 2009-03-02
KR100589299B1 (ko) 2006-06-14
ZA200004178B (en) 2002-04-24
ATE254920T1 (de) 2003-12-15
AU762322B2 (en) 2003-06-26
PL342988A1 (en) 2001-07-16
HUP0101246A2 (hu) 2002-05-29
AU762322C (en) 2004-02-12
AU3417199A (en) 1999-10-18
PT1083902E (pt) 2004-04-30
EP1083902B1 (de) 2003-11-26
DE59907871D1 (de) 2004-01-08
CA2326517C (en) 2008-06-10
JP3639532B2 (ja) 2005-04-20
HK1034183A1 (en) 2001-10-19
EP0945134A1 (de) 1999-09-29
KR20010034698A (ko) 2001-04-25
UY25441A1 (es) 1999-11-17
NO20004823L (no) 2000-11-22
NO20004823D0 (no) 2000-09-26
IL137652A (en) 2006-10-05
JP2002509886A (ja) 2002-04-02
BR9909192A (pt) 2000-12-05
AR016197A1 (es) 2001-06-20
DK1083902T3 (da) 2004-03-29
CA2326517A1 (en) 1999-10-07
IL137652A0 (en) 2001-10-31
TWI236914B (en) 2005-08-01
EP1083902A1 (de) 2001-03-21
ES2212547T3 (es) 2004-07-16
CN1295478A (zh) 2001-05-16
HUP0101246A3 (en) 2002-08-28
PL192967B1 (pl) 2006-12-29
WO1999049867A1 (de) 1999-10-07
CN1163231C (zh) 2004-08-25

Similar Documents

Publication Publication Date Title
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
DE60326354D1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
SE9900961D0 (sv) Novel compounds
AR032293A1 (es) Estuche farmaceutico
DK1365808T3 (da) Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
NO20065904L (no) Terapeutiske forbindelser
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
GB0222514D0 (en) Organic compounds
SE9802208D0 (sv) Novel compounds
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
DE602004016376D1 (de) Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
SE9802209D0 (sv) Novel compounds
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
GEP201606538B (en) Preoperative treatment of post operative pain
EA200401454A1 (ru) Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
DE60327249D1 (de) Anthranilsäureamide und ihre pharmazeutische verwendung
SE0101258D0 (sv) Treatment of low back pain and whiplash associated disorder
NO20032799D0 (no) Nye terapeutiske anvendelser av tienylsykloheksylamin- derivater
EA200101157A1 (ru) 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ